AXIM (AXIM Biotechnologies) Cash per Share: $0.00 (As of Jun. 2025)

What is AXIM Biotechnologies Cash per Share?

AXIM Biotechnologies AXIM +9.09% Cash per Share is $0.00 as of Jun. 2025.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). AXIM Biotechnologies's Cash per Share for the quarter that ended in Jun. 2025 was $0.00.

AXIM Biotechnologies (OTCPK:AXIM) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

AXIM Biotechnologies Cash per Share Related Terms

AXIM Biotechnologies Cash per Share Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Cash per Share Chart

AXIM Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash per Share

Get a 7-Day Free Trial

0.00

AXIM Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25
Cash per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

AXIM Biotechnologies Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

AXIM Biotechnologies's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0	/	318.90
	=	0.00

AXIM Biotechnologies's Cash per Share for the quarter that ended in Jun. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.003	/	332.96
	=	0.00

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of $0.00 mean?

AXIM Biotechnologies (AXIM) has a Cash per Share of $0.00 as of Jun. 2025. Cash per share is the per-share value of a company's available cash. View historical data for AXIM Biotechnologies and its competitors.

Is AXIM Biotechnologies' Cash per Share too high?

AXIM Biotechnologies' current Cash per Share is $0.00.

How does AXIM Biotechnologies' Cash per Share compare to ZVSA and HEPA?

AXIM Biotechnologies' Cash per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Biotechnology company?

A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Cash per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AXIM Biotechnologies stock overvalued right now?

AXIM Biotechnologies (AXIM) has a current Cash per Share of $0.00. The current Cash per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Cash per Share is $0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Industry Healthcare Biotechnology

Comparable Companies ZVSA HEPA ISCO BPTH ABPO SCNI VBIO EVFM LYRA CLSDQ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121

Website https://www.aximbiotech.com

AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.